Document ID: chunk:federal_register_of_legislation:F2021C00104:schedule:1:p42
Version: federal_register_of_legislation:F2021C00104
Segment Type: schedule
Provision Reference: sch 1 (pt 42/43)
Character Range: 122228–124976

1 to the Sport Integrity Australia Amendment (World Anti‑Doping Code Review) Regulations 2020 applies in relation to a request for a sample made on or after the commencement of this clause.
 (2) Clause 3.12A of this Schedule, as inserted by Schedule 1 to the Sport Integrity Australia Amendment (World Anti‑Doping Code Review) Regulations 2020, applies in relation to a sample given on or after the commencement of this clause.
 (3) The amendments of clauses 3.16 and 3.19 of this Schedule made by Schedule 1 to the Sport Integrity Australia Amendment (World Anti‑Doping Code Review) Regulations 2020 apply in relation to a request for a sample made on or after the commencement of this clause.
 (4) The amendments of clause 3.20 of this Schedule made by Schedule 1 to the Sport Integrity Australia Amendment (World Anti‑Doping Code Review) Regulations 2020 apply in relation to a permission given on or after the commencement of this clause.
 (5) The amendments of clause 3.24 of this Schedule, and the repeal of clause 3.25 of this Schedule, made by Schedule 1 to the Sport Integrity Australia Amendment (World Anti‑Doping Code Review) Regulations 2020 apply in relation to a sample given on or after the commencement of this clause.

7.16  Results management
 (1) The following amendments apply in relation to notice the CEO receives, on or after the commencement of this clause, from a recognised laboratory of an atypical finding or an adverse analytical finding in relation to an A sample provided by an athlete:
  (a) the amendment of Division 4.1 of Part 4 of this Schedule made by Schedule 1 to the Sport Integrity Australia Amendment (World Anti‑Doping Code Review) Regulations 2020;
 (b) the amendments of Divisions 4.3, 4.4 and 4.5 of Part 4 of this Schedule made by Schedule 1 to those regulations, so far as they relate to the amendment covered by paragraph (a).
 (2) The following amendments apply in relation to evidence or information the CEO receives, on or after the commencement of this clause, showing a possible non‑presence anti‑doping rule violation:
 (a) the amendments of Division 4.2 of Part 4 of this Schedule made by Schedule 1 to the Sport Integrity Australia Amendment (World Anti‑Doping Code Review) Regulations 2020;
 (b) the amendments of Divisions 4.3, 4.4 and 4.5 of Part 4 of this Schedule made by Schedule 1 to those regulations, so far as they relate to the amendments covered by paragraph (a).
 (3) The amendments of clause 4.21 of this Schedule made by Schedule 1 to the Sport Integrity Australia Amendment (World Anti‑Doping Code Review) Regulations 2020 apply in relation to the disclosure of information, documents or things on or after the commencement of this clause, whether the information, documents